Evidence map›Paper›PMID 42072483›Full record

ArticleBiomedicines2026

Single Cell and Bulk RNA-Seq Profiling of Non-Metastatic Versus Bone-Metastatic Prostate Cancer Identifies the CXCL10-CXCR3 Axis as a Key Determinant of Tumor Microenvironment and Treatment Resistance.

Zijian Song, Likai Ren, Hong Wang, Yanqing Wang, Xinxing Du, Wei Zhou, Qi Zhang, Jiyuan Yu, Zaixu Zhao, Linxiong Ye and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zijian SongDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Likai RenDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Hong WangDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Yanqing WangDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Xinxing DuDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Wei ZhouDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Qi ZhangDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Jiyuan YuDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Zaixu ZhaoDepartment of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, China.ORCID 0009-0003-5259-0030
Linxiong YeDepartment of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, China.ORCID 0009-0001-4837-543X
Kaidi JinDepartment of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai 201203, China.ORCID 0009-0008-7571-1276
Ying LiuJiangsu Provincial Engineering Research Center of Cancer Cell Therapy and Translational Medicine, Xuzhou City Engineering Research Center of Cancer Cell Therapy and Translational Medicine, Xuzhou Central Hospital, Southeast University, Xuzhou 221009, China.
Wei XueDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Funding

Beijing Xisike Clinical Oncology Research Foundation Y-Young2024-0036Excellent Talents Fund, Affiliated Hospital of Xuzhou Medical University XYFY202405General Program State Administration of Traditional Chinese Medicine of Jiangsu MS2025062
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bone metastasisbulk RNA sequencingCXCL10-CXCR3 axisprostate cancersingle-cell sequencingtumor microenvironment

Identifiers

PMID42072483
PMCPMC13113686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.